-
Nippon India Pharma IDCW-R
Equity healthcare
Overview ( as on 12/09/25 )
NAV
₹120.94
Last change
₹0.43 +0.0%
Fund Size (AUM)
8357.03 Cr
Performance
21.47% (5Y)
Fund Details
Nippon India Pharma IDCW-R
as of 12/09/25
AUM
8357.03 Cr
Expense Ratio
1.8 %
Benchmark
BSE Healthcare TR INR
ISIN
INF204K01943
Fund Manager
Sailesh Raj Bhan
Exit Load
1.0% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Nippon India Pharma IDCW-R | -1.79% | 22.2% | 21.47% |
| BSE Healthcare TR INR | 1.03% | 23.76% | 18.86% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
11.94% |
Divi's Laboratories Ltd |
7.34% |
Cipla Ltd |
6.09% |
Lupin Ltd |
6.09% |
Apollo Hospitals Enterprise Ltd |
5.91% |
Dr Reddy's Laboratories Ltd |
5.9% |
Medplus Health Services Ltd |
3.65% |
Vijaya Diagnostic Centre Ltd |
3.48% |
GlaxoSmithKline Pharmaceuticals Ltd |
3.04% |
Gland Pharma Ltd |
2.96% |
Sector Allocation
Healthcare |
100.0% |
Asset Allocation
-
99%
Equity
-
1%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
21.78% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
21.08% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
20.79% (5Y)
-
-
SBI Healthcare Opportunities IDCW-R
Equity healthcare-
Returns
-
20.79% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
19.25% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
19.25% (5Y)
-
